Daftar Pustaka

1. Rodrigues A, at al. Biogenic Antimicrobial Silver Nanoparticles Produced by Fungi. Applied Microbial And Cell Physiology. 2012 2. Wah Mak J. Pathology Of Lymphatic Filariasis. Iejsme 2012: 6 (Suppl 1): S80S86 3. Figueredo J, Noro J, Cedenho A, Dreyer G. The Histopathology Of Bancroftian Lariasis Revisited:The Role Of The Adult Worm In The Lymphatic-Vessel Disease. Annals Of Tropicalmedicine & Parasitology. 2002;96(6):531541 4. Vaqas B, Ryan Tj. Lymphoedema: Pathophysiology and Management in Resource-Poor Settings - Relevance For Lymphatic Filariasis Control Programmes. Filaria Journal. 2003 5. David G, Molly A. Morbidity Management in the Global Programme to Eliminate Lymphatic Filariasis: A Review of the Scientific Literature. Filaria Jurnal.2007 6. Krishna K, Harichandrakumar, Das Lk, Krishnamoorthy K. Physical and Psychosocial Burden Due to Lymphatic Filariasis As Perceived by Patients And Medical Experts. Tropical Medicine and International Health. 2005:567-573 7. Asharani Pv, Grace Low Kah Mun, Manoor Prakash Hande, Suresh Valiyaveetti. Cytotoxicity And Genotoxicity Of Silver Nanoparticles In Human Cells. American Chemical Society.2009:279-290 8. Dhrutika Patel, Miral Patel, Krishnamurthy R. Silver Nanoparticles: Biosynthesis and Its Antimicrobial Activity. Cibtech Journal of Bio-Protocols. 2013;2(1):50-57 9. Nagender Rp, Eladia M, Josef H. Silver or Silver Nanoparticles: A Hazardous Threat to the Environment and Human Health?.Journal of Applied Medicine. 2008 10. Thabet M. Tolaymat, Amro M. El Badawy, Ash Genaidy, Kirk G. Scheckel, Todd P. Luxton, Makram Suidan. An Evidence-Based Environmental Perspective of Manufactured Silver Nanoparticle in Syntheses and

Applications: A Systematic Review and Critical Appraisal of Peer-Reviewed Scientific Papers. Science of the Total Environment. 2010: 9991006 11. Avinash Kumar Reddy, Jyothi M Joy, Trilok Mitra, Shaik Shabnam, T. Shilpa. Nano Silver A Review. International Journal of Advanced Pharmaceutics. 2012 12. Venkataraman D, Kalimuthu K, Sureshbabu R, Sangiliyandi G. An Insight Into The Bacterial Biogenesis of Silver Nanoparticles, Industrial Production And Scale-Up. 13. Kaushik N, Ms, Snehit S, Rasesh Y. Biological Synthesis of Metallic Nanoparticles. Nanomedicine: Nanotechnology, Biology, and Medicine. 2009 14. Khabat V, Ali M, Sedighe K. Biosynthesis of Silver Nanoparticles by Fungus Trichoderma Reesei. (A Route For Large-Scale Production Of Agnps). Insciences J. 2011, 1(1), 65-79 15. Gyapong M, Gyapong J,Owusu-Banahene. Community-Directed Treatment: the Way Forward to Eliminating Lymphatic . Lariasis As A Public-Health Problem In Ghana. Annals of Tropical Medicine & Parasitology.2001:vol. 95, no. 1, 77 86 16. Moses J, Rinki M. Elimination of Lymphatic Filariasis: Do We Have the Drugs to Complete the Job?. Current Opinion In Infectious Diseases. 2010,23:617 620 17. Gyapong M. Socio-Cultural Aspects of Lymphatic Filariasis and the Role of Communities in Its Control in Ghana. Universtt Basel. 2000 18. Sunil K, Kalyan G, Richa D, Maryada Vr, Debabrata D. Novel Microfilaricidal Activity of Nanosilver. International Journal of Nanomedicine. 2012 19. George A, David G, Patrick J. Characterization of Antibody Responses to Wolbachia Surface Protein in Humans With Lymphatic Filariasis. American Society for Microbiology. 2003 20. Joseph D, et al. Lipids and Lipoproteins: Metabolism, Regulation, and Signaling: Wolbachia Lipoprotein Stimulates Innate and Adaptive Immunity

Through Toll-Like Receptors 2 and 6 to Induce Disease Manifestations of Filariasis. The Journal Of Biological Chemistry. 2009 21. Witt C, Ottesen Ea. Lymphatic Lariasis: An Infection of Childhood. Tropical Medicine and International Health. 2001 22. Simon A, Andrew F, Rachel A, Odile B, Judith E. Filarial Parasites Develop Faster and Reproduce Earlier in Response to Host Immune Effectors That Determine Filarial Life Expectancy. Plos Biology. 2010 23. Sasisekhar B, Thomas B. Lymphangiogenesis and Lymphatic Remodeling Induced by Filarial Parasites: Implications for Pathogenesis. Plos Pathogens. 2009 24. Paul B, Thomas B. Update on Lymphaatic Filarial Infections. Topical And Travel Medicine 25. Sasisekhar B, Thomas B. Lymphatics in Human Lymphatic Filariasis: In Vitro Models of Parasite-Induced Lymphatic Remodeling. Lymphatic Research and Biology. 2009 26. Wink M. Medicinal Plants: A Source of Anti-Parasitic Secondary Metabolites. Molecules. 2012 27. Nick F, Mark W, David C, Mabey, Anthony W. Neglected Tropical Diseases. British Medical Bulletin. 2010:179-200 28. Pfarr Km, Debrah Ay, Specht S, Hoerauf A. Filariasis and Lymphedema. Parasite Immunology. 2009:664-572 29. Thomas B. Lymphatic Filariasis: New Insights and Prospects for Control. Current Opinion in Infectious Diseases. 2001 30. Taylor Mj, Wolbachia Endosymbiotic Bacteria of Filarial Nematodes. A New Insight Into Disease Pathogenesis and Control. Archives Of Medical Research. 2002:422-424 31. Asharani Pv, Grace L, Manoor Ph, Suresh V. Cytotoxicity And Genotoxicity of Silver Nanoparticles in Human Cells. American Chemical Society. 2009 32. Hoerauf A. Filariasis: New Drugs and New Opportunities for Lymphatic Filariasis and Onchocerciasis. Wolters Kluwer Health. 2008;21:673-81